We are live on ! Find out more
CEP

Chicago Equity Partners Portfolio holdings

AUM $993M
1-Year Est. Return 6.42%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
-6.42%
3 Year Est. Return
+34.83%
5 Year Est. Return
+90.28%
10 Year Est. Return
AUM
$3.63B
AUM Growth
+$297M
Cap. Flow
+$186M
Cap. Flow %
5.12%
Top 10 Hldgs %
16.99%
Holding
521
New
107
Increased
188
Reduced
135
Closed
77

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$41.7M
2
STJ
St Jude Medical
STJ
+$28.9M
3
C icon
Citigroup
C
+$27.7M
4
AES icon
AES
AES
+$22.8M
5
NFLX icon
Netflix
NFLX
+$21.9M

Sector Composition

Rank Sector Weight
1 Financials 16.21%
2 Industrials 13.73%
3 Healthcare 12.86%
4 Technology 10.89%
5 Energy 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALGN icon
176
Align Technology
ALGN
$12B
$3.24M 0.09%
62,655
+56,755
+962% +$3.18M
ACM icon
177
Aecom
ACM
$9.07B
$3.2M 0.09%
99,560
+34,450
+53% +$1.05M
WEC icon
178
WEC Energy
WEC
$37.7B
$3.12M 0.09%
67,010
+4,600
+7% +$198K
LECO icon
179
Lincoln Electric
LECO
$13.8B
$3.08M 0.08%
42,755
+1,660
+4% +$119K
HAR
180
DELISTED
Harman International Industries
HAR
$3.07M 0.08%
+28,870
New +$2.88M
NI icon
181
NiSource
NI
$22.4B
$3.06M 0.08%
219,226
-222,433
-50% -$3.01M
ITT icon
182
ITT
ITT
$17.5B
$3.04M 0.08%
71,165
+2,220
+3% +$94.3K
AGCO icon
183
AGCO
AGCO
$8.78B
$3.03M 0.08%
54,950
-356,925
-87% -$19.1M
HSIC icon
184
Henry Schein
HSIC
$9.74B
$2.93M 0.08%
62,666
-13,719
-18% -$627K
HII icon
185
Huntington Ingalls Industries
HII
$11.3B
$2.88M 0.08%
28,160
+1,560
+6% +$151K
IDTI
186
DELISTED
Integrated Device Technology I
IDTI
$2.82M 0.08%
+230,500
New +$2.61M
AZPN
187
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$2.8M 0.08%
66,125
+35,240
+114% +$1.49M
INVX
188
Innovex International
INVX
$1.87B
$2.75M 0.08%
24,505
-11,180
-31% -$1.16M
MAR icon
189
Marriott International
MAR
$98.7B
$2.7M 0.07%
+48,130
New +$2.49M
RGA icon
190
Reinsurance Group of America
RGA
$15.7B
$2.67M 0.07%
+33,525
New +$2.55M
MFA
191
MFA Financial
MFA
$929M
$2.63M 0.07%
+84,809
New +$2.55M
ESRX
192
DELISTED
Express Scripts Holding Company
ESRX
$2.6M 0.07%
34,569
-13,950
-29% -$1.04M
ETR icon
193
Entergy
ETR
$54.1B
$2.55M 0.07%
+76,350
New +$2.41M
ANN
194
DELISTED
ANN INC
ANN
$2.55M 0.07%
61,495
-24,345
-28% -$869K
SEIC icon
195
SEI Investments
SEIC
$11.9B
$2.52M 0.07%
74,920
+2,400
+3% +$81.6K
DINO icon
196
HF Sinclair
DINO
$15.9B
$2.52M 0.07%
52,880
+19,630
+59% +$928K
AYI icon
197
Acuity Brands
AYI
$9.88B
$2.5M 0.07%
+18,825
New +$2.49M
SLXP
198
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$2.48M 0.07%
+23,965
New +$2.45M
AMGN icon
199
Amgen
AMGN
$203B
$2.47M 0.07%
20,037
-344,062
-94% -$41.7M
RAMP icon
200
LiveRamp
RAMP
$2.29B
$2.46M 0.07%
+71,555
New +$2.58M

Similar funds

Chicago Equity Partners's Q1 2014 Portfolio in Review

As of Q1 2014, Chicago Equity Partners held 521 positions worth $3.63B, up 8.9% from $3.33B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Chicago Equity Partners deployed $186M of net new capital in Q1 2014, opening 107 new positions and adding to 188 existing holdings. Its largest new stake was Gilead Sciences: 530,865 shares worth $37.6M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $41.7M trimmed.

  • Chicago Equity Partners's largest Q1 2014 buy was Gilead Sciences: 530,865 shares worth $37.6M.
  • Chicago Equity Partners added most to Pitney Bowes in Q1 2014, an estimated $34.5M increase.
  • Chicago Equity Partners's biggest Q1 2014 reduction was Amgen, cutting an estimated $41.7M.
  • Chicago Equity Partners fully exited AES in Q1 2014, selling an estimated $22.8M.
  • Chicago Equity Partners's ten largest holdings make up 17% of its $3.63B portfolio in Q1 2014.
  • Chicago Equity Partners opened 107 new positions and closed 77 in Q1 2014.
  • Chicago Equity Partners's portfolio value rose 8.9% quarter-over-quarter to $3.63B.

Based on Chicago Equity Partners's 13F filing for Q1 2014, filed 2 May 2014.